Paam Antibiotics Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 2.40 Cr
- Company Age 32 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
- Revenue Growth %
- Profit Growth -26.89%
- Ebitda -30.90%
- Net Worth -1.49%
- Total Assets -0.06%
About Paam Antibiotics
Paam Antibiotics Limited (PAL) is a Public Limited Indian Non-Government Company incorporated in India on 13 April 1992 and has a history of 32 years and nine months. Its registered office is in Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 2.40 Cr.
The company currently has active open charges totaling ₹2.50 M.
Aparna Agnihotri, Mukesh Bhargava, and Rajesh Mishra serve as directors at the Company.
Company Details
-
Location
Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239DL1992PLC048340
-
Company No.
048340
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
13 Apr 1992
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Paam Antibiotics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aparna Agnihotri
|
Director | 12-Mar-2009 | Current |
|
Mukesh Bhargava
|
Director | 13-Apr-1992 | Current |
|
Rajesh Mishra
|
Director | 11-Jan-2022 | Current |
Financial Performance of Paam Antibiotics.
Paam Antibiotics Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 26.89% decrease in profit. The company's net worth dipped by a decrease of 1.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paam Antibiotics?
In 2023, Paam Antibiotics had a promoter holding of 4.65% and a public holding of 95.35%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Society Distributors Private LimitedAparna Agnihotri is a mutual person
-
Paam Eatables LimitedMukesh Bhargava is a mutual person
-
Paam Housing Development Finance LimitedAparna Agnihotri and Mukesh Bhargava are mutual person
-
Societydistribution. Llp
Aparna Agnihotri is a mutual person
-
Nuexim Private Limited
Aparna Agnihotri and Rajesh Mishra are mutual person
Charges (Loans)
₹0.25 Cr
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 1997 | Syndicate Bank | ₹2.50 M | Open |
How Many Employees Work at Paam Antibiotics?
Unlock and access historical data on people associated with Paam Antibiotics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paam Antibiotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paam Antibiotics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
